Cardiotoxicity Monitoring With Single-lead Electrocardiogram

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 10, 2020

Primary Completion Date

May 25, 2023

Study Completion Date

May 25, 2023

Conditions
Cardiotoxicity
Interventions
DEVICE

Remote 1-minute single-lead electrocardiogram (ECG) monitoring in cancer patients after the first polychemotherapy cycle.

Recording of the ECG using smart-phone at rest, 15 minutes before registering ECG patient should not smoke,having tea, coffee, alcohol. During the ECG recording hands should be fixed to avoid poor quality. Patient sitting on a char with tow hands fixed on a table holding electrocardiograph with index fingers placed at the ECG electrode (left) and at the photoplethysmograph sensor(right).ECG signals are recorded from the fingers using first standard ECG lead. After registration, all ECG and photoplethysmography data will be sent to the server. The data will be automatically compared with a standard for data quality, after that the data will be sent to cardiologist. If quality will be not sufficient, the data will be deleted and the doctor will contact the patient to solve the quality issue. Thereafter, the parameters will be carried out by cardiologist, on the basis of which value of ECG monitoring will be estimated.

Trial Locations (1)

119991

I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow

All Listed Sponsors
lead

I.M. Sechenov First Moscow State Medical University

OTHER

NCT05676606 - Cardiotoxicity Monitoring With Single-lead Electrocardiogram | Biotech Hunter | Biotech Hunter